Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray O Robinson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cell Cycle (Georgetown, Tex.)|July 24, 2009
Human-in-mouse breast cancer modelMin Wu, Murray O Robinson
Oncogene|February 19, 2002
Telomere dysfunction: multiple paths to the same endLea Harrington, Murray O Robinson
Current Oncology Reports|February 15, 2011
Development of second-generation VEGFR tyrosine kinase inhibitors: current statusPankaj Bhargava, Murray O Robinson
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2002
Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTertYie Liu, Hue Kha, Mark Ungrin, et al.
Current Biology : CB|April 18, 2003
Functional conservation of the telomerase protein Est1p in humansBryan E Snow, Natalie Erdmann, Jennifer Cruickshank, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2009
Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in miceMin Wu, Lina Jung, Adrian B Cooper, et al.
Nature Biotechnology|December 22, 2009
Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomasYinghui Zhou, William M Rideout, Tong Zi, et al.
Cancer Research|November 12, 2009
De novo discovery of a gamma-secretase inhibitor response signature using a novel in vivo breast tumor modelJames W Watters, Chun Cheng, Pradip K Majumder, et al.
Genes & Development|May 18, 2011
Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stressKathrin Zaugg, Yi Yao, Patrick T Reilly, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cell Cycle (Georgetown, Tex.)|July 24, 2009
Human-in-mouse breast cancer modelMin Wu, Murray O Robinson
Oncogene|February 19, 2002
Telomere dysfunction: multiple paths to the same endLea Harrington, Murray O Robinson
Current Oncology Reports|February 15, 2011
Development of second-generation VEGFR tyrosine kinase inhibitors: current statusPankaj Bhargava, Murray O Robinson
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2002
Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTertYie Liu, Hue Kha, Mark Ungrin, et al.
Current Biology : CB|April 18, 2003
Functional conservation of the telomerase protein Est1p in humansBryan E Snow, Natalie Erdmann, Jennifer Cruickshank, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2009
Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in miceMin Wu, Lina Jung, Adrian B Cooper, et al.
Nature Biotechnology|December 22, 2009
Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomasYinghui Zhou, William M Rideout, Tong Zi, et al.
Cancer Research|November 12, 2009
De novo discovery of a gamma-secretase inhibitor response signature using a novel in vivo breast tumor modelJames W Watters, Chun Cheng, Pradip K Majumder, et al.
Genes & Development|May 18, 2011
Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stressKathrin Zaugg, Yi Yao, Patrick T Reilly, et al.
Pageof 1